IHC showed that CDCA5 knockdown (Fig. 7a; P < 0.05 vs. sh-Ctrl) significantly decreased proliferating cell nuclear antigen (PCNA) expression in xenograft tumor (Fig. 7b; P < 0.05 vs. sh-Ctrl). This evidence concerns the gene CDCA5 and neoplasm.